Department of Biochemistry
Our research integrates metabolomics, biochemistry and vascular functional-structural studies into translational medical outputs for disease prevention, diagnostics (including subclinical), and development of advanced therapies. As an integration of clinical metabolomics, biochemical methods and functional-structural analysis of arteries, we have been developing research over the last two years so that the aggregate output of the next six years will make a significant contribution to the development of a novel translational medicine research platform (arteriobolomics). The main focus is on cardiovascular disease (particularly atherosclerosis of the lower limbs), primary episode psychosis and chronic obstructive pulmonary disease (COPD) as one of the main causes of disability and death in the European Union.
Department of Bichemistry, October 2016